Next-gen sequencing for the next generation

An early summer science smorgasbord

A blood test for Parkinson’s disease?

Feature Focus: Are cancer-screening tests worth taking?

Biden’s Dx highlights challenges with prostate-cancer screening

AI mines primary-care data to diagnose cancer

Don’t let perfect be the enemy of the good in colon cancer screening

Spotlight on Alzheimer’s: The biomarker race

The Diagnostics Year in Review

A breath test for lung cancer?

When and how will we know if MCEDs are worth it?

FDA’s Final Rule on LDTs is dead